Pharmaceutical giant GSK has struck a deal worth up to 1.4 billion US dollars (£1.1 billion) to buy asthma drug firm Aiolos Bio. The takeover of the three-month-old start-up is part of GSK’s ...

GSK (NYSE:GSK) said on Tuesday that it will acquire clinical-stage biopharmaceutical company Aiolos Bio for a $1B upfront payment and up to $400M on achieving certain regulatory milestones.

The Orifices -- Where Most of Medicine's Money Is Made Over the course of a long career, Dr Lundberg has witnessed huge, even astounding advances in what he calls orificial medicine.

The move follows phase 1/2 results with SK bio's GBP510, which found that it stimulated ... subject to data and regulatory review," said GSK in a statement this morning. COVAX is a World Health ...

GSK’s blockbuster hopes for depemokimab remain on track after the investigational long-acting asthma treatment has also been shown to reduce nasal polyps in a pair of phase 3 trials. The ANCHOR ...

GSK’s vaccine portfolio. GSK’s portfolio of more than 20 marketed vaccines, one of the industry’s broadest, protects people against diseases such as meningitis, shingles, polio, measles ...

This is a void best filled with a service like Linktree that enables users to create a landing page full of other links. This way, you'd only have to add a single link in your bio or under a post.

GSK acquired Zejula as part of its $5.1 billion takeover of Tesaro in 2018, along with other oncology drug candidates, including latecomer PD-1 inhibitor Jemperli (dostarlimab) and others ...

Starting his career as a manager in the American Wrestling Association in the late '80s, Diamond Dallas Page made his first WWE appearance in 1990 when he drove The Honky Tonk Man and Greg ...

The question then is whether there will be lawyers willing to cloak this insistence in the language of legal reasoning and therefore to assist him in litigating his way back to the White House.

On Monday, GSK plc (NYSE:GSK) released headline results from the phase 3 trials ANCHOR-1 and ANCHOR-2, which assessed the efficacy and safety of depemokimab versus placebo in adults with chronic ...